Methyl Anthranilate → HCID 57717920, compound
Reaction equation
C[O:2][C:3](=[O:11])[C:4]1[CH:9]=[CH:8][CH:7]=[CH:6][C:5]=1[NH2:10].[C:12]([C:16]1[CH:41]=[CH:40][C:19]([O:20][C:21]2[CH:30]=[C:29]3[C:24]([CH:25]=[C:26]([C:37](Cl)=[O:38])[N:27]=[C:28]3[CH2:31][CH:32]3[CH2:36][CH2:35][CH2:34][CH2:33]3)=[CH:23][CH:22]=2)=[CH:18][CH:17]=1)([CH3:15])([CH3:14])[CH3:13]>>[C:12]([C:16]1[CH:41]=[CH:40][C:19]([O:20][C:21]2[CH:30]=[C:29]3[C:24]([CH:25]=[C:26]([C:37]([NH:10][C:5]4[CH:6]=[CH:7][CH:8]=[CH:9][C:4]=4[C:3]([OH:2])=[O:11])=[O:38])[N:27]=[C:28]3[CH2:31][CH:32]3[CH2:33][CH2:34][CH2:35][CH2:36]3)=[CH:23][CH:22]=2)=[CH:18][CH:17]=1)([CH3:15])([CH3:13])[CH3:14]Participants
3
Procedure
The title compound (30 mg) was prepared following the same procedures that was described for example 432 from methyl-2-aminobenzoate (0.1 mmol, 15.1 mg) and 7-(4-tert-butyl-phenoxy)-1-cyclopentylmethyl-isoquinoline-3-carbonyl chloride (46 mg, 0.1 mmol).
Sources & evidence
- ORD record
- ord-7028071934724ff2a5033b5e87de2789
- Source dataset
- uspto-grants-2009_06
- Patent number
- US07544699B2
Reaction notes
Loading…